Walgreens Boots Alliance Inc. (NASDAQ: WBA) announced the latest financial results before the market open in the US on Tuesday.
The company beat both revenue and earnings per share (EPS) estimates.
Walgreens reported revenue of $34.862 billion for the quarter ending February 28, 2023 (up by 3.3% year-over-year) vs. $33.528 billion expected.
EPS reported at $1.16 per share (down by 27.2% year-over-year) vs. $1.103 per share estimate.
CEO commentary
“WBA exited a solid second quarter with acceleration in February, adding to our confidence in driving strong growth in the second half of the year. With the closing of VillageMD’s acquisition of Summit Health, WBA is now one of the largest players in primary care, with best-in-class assets across the care continuum. Both Walgreens and Boots are performing well by delivering compelling value to consumers, playing a critical role as community health destinations, and successfully navigating a challenging environment. We will continue to take bold actions to create sustainable long-term shareholder value,” CEO of the company, Rosalind Brewer said in a press release.
The stock was up by around 1% in pre-market trading following the latest results.
The stock is down by 11.83% year-to-date at $32.96 a share.
Stock performance
Walgreens Boots Alliance price targets
Walgreens Boots Alliance Inc. is the 605th largest company in the world with a market cap of $28.41 billion.
You can trade Walgreens Boots Alliance Inc. (NASDAQ: WBA) and many other stocks from the NYSE, NASDAQ, HKEX, ASX, LSE and DE with GO Markets as a Share CFD.
Sources: Walgreens Boots Alliance Inc., TradingView, MarketWatch, MetaTrader 5, Benzinga, CompaniesMarketCap
Disclaimer: Articles are from GO Markets analysts and contributors and are based on their independent analysis or personal experiences. Views, opinions or trading styles expressed are their own, and should not be taken as either representative of or shared by GO Markets. Advice, if any, is of a ‘general’ nature and not based on your personal objectives, financial situation or needs. Consider how appropriate the advice, if any, is to your objectives, financial situation and needs, before acting on the advice. If the advice relates to acquiring a particular financial product, you should obtain and consider the Product Disclosure Statement (PDS) and Financial Services Guide (FSG) for that product before making any decisions.
US stocks declined modestly in a fairly quiet session with most of the downside coming from Tech stocks whose future valuation become less attractive as bond yields rose, with the Nasdaq finishing down almost 0.5% while the Dow and S&P 500 were almost unchanged. The only real news out overnight was US consumer confidence which rose to 104 fr...
As the banking crisis subside slightly with the news of First Citizens bank’s acquisition of Silicon Valley Bank (SVB), the DXY has reversed from th...